Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
(S)-(+)-Dimethindene maleate: Protocols for M2 Antagonist Re
2026-05-13
(S)-(+)-Dimethindene maleate addresses the need for a selective M2 muscarinic and H1 histamine receptor antagonist in autonomic regulation, cardiovascular, and respiratory function research. It is not recommended for diagnostic or clinical use and should be employed strictly in well-controlled laboratory workflows where receptor selectivity and solution stability are critical.
-
ATM Inhibition and Metabolic Synergy in Ovarian Cancer Cells
2026-05-13
This study demonstrates that targeting the ATM kinase, a central regulator of homologous recombination-mediated DNA repair, can sensitize high grade serous ovarian cancer (HGSOC) cells to metabolic intervention with fenofibrate. The research provides mechanistic and empirical evidence for the synergistic induction of senescence in HR-proficient HGSOC cells, highlighting a promising therapeutic strategy for a patient subgroup with limited treatment options.
-
Simvastatin (Zocor): Optimizing Lipid and Cancer Cell Assays
2026-05-12
Simvastatin (Zocor) from APExBIO is a cornerstone tool for dissecting cholesterol biosynthesis and anti-cancer pathways, with proven utility in both hepatic and prostate cancer models. This article delivers a practical, evidence-driven workflow, troubleshooting guidance, and actionable insights for researchers seeking robust, reproducible outcomes in lipid metabolism and oncology.
-
Structure-Based Inhibitor Discovery for SARS-CoV-2 NSP15: In
2026-05-12
This study applied structure-based virtual screening to identify natural product inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease involved in immune evasion. Thymopentin and oleuropein emerged as stable, high-affinity inhibitors, offering new leads for antiviral research and combinatorial treatment strategies.
-
10 mM dNTP Mixture: Enabling Advanced DNA Synthesis & LNP As
2026-05-11
The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO streamlines PCR, qPCR, DNA sequencing, and lipid nanoparticle (LNP) delivery research. Discover how its equimolar, pH-stable formulation boosts reproducibility, troubleshooting, and cutting-edge protocol performance.
-
Lypressin Acetate: Mechanistic Insight and Translational Val
2026-05-11
This thought-leadership article explores the mechanistic depth and translational guidance surrounding Lypressin acetate, a lysine vasopressin analog distinguished by its precise G protein-coupled receptor targeting, robust quantitative data, and practical advantages in both classic and emerging research domains. We integrate peer-reviewed evidence and real-world workflow recommendations to provide actionable strategies for researchers navigating the complexities of diabetes insipidus modeling, vasoconstriction research, and antiviral studies, while highlighting the unique positioning of APExBIO's Lypressin acetate and bridging current knowledge to future opportunities.
-
IWP-2 in Cancer Research: Precision PORCN Inhibition & Advan
2026-05-10
Explore how IWP-2, a potent Wnt production inhibitor, enables precision assay development and transformative insights in cancer research. This article uniquely connects molecular mechanism, assay optimization, and cross-disciplinary advances, offering practical guidance beyond standard protocol.
-
High Viscosity Microenvironments Induce P-gp-Driven Chemores
2026-05-09
This study reveals that elevated extracellular fluid viscosity in the tumor microenvironment promotes chemoresistance by upregulating P-glycoprotein (P-gp) expression through a mechanotransduction pathway involving cytoskeletal remodeling, membrane tension, TRPV4 activation, and YAP signaling. These findings highlight the importance of considering mechanical cues in drug resistance research and suggest that targeting microenvironmental viscosity or its downstream signaling could improve cancer chemotherapy outcomes.
-
Estradiol Benzoate: Applied Workflows for Estrogen Receptor
2026-05-08
Estradiol Benzoate, a high-purity synthetic estradiol analog, is a gold-standard tool for estrogen receptor alpha agonist studies. This article distills advanced use-cases, stepwise protocols, and troubleshooting strategies to maximize reproducibility and data fidelity in hormone receptor binding and signaling assays.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Workflow Answers & Da
2026-05-08
This article addresses common laboratory challenges in apoptosis detection using the Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003). Through scenario-driven Q&A, we analyze protocol optimization, data interpretation, and product reliability, providing actionable, evidence-based guidance for researchers and technicians. The article highlights reproducibility and workflow efficiency for SKU K2003, supporting confident adoption in apoptosis research.
-
SB 431542: Precision ALK5 Inhibition in Vascular and Immunol
2026-05-07
Explore how SB 431542, a leading ALK5 inhibitor, enables advanced dissection of TGF-β signaling in vascular remodeling and anti-tumor immunology. This article delivers new insights for researchers seeking rigorous control over cell proliferation and migration.
-
A1 Astrocyte–Microglia Crosstalk via p38 MAPK in Neuroinflam
2026-05-07
This study reveals that 2-chloroethanol activates A1 astrocytes through ROS-induced p38 MAPK/NF-κB and AP-1 pathways, which in turn drive pro-inflammatory M1 microglia polarization. The findings clarify glial crosstalk mechanisms in 1,2-dichloroethane-induced neuroinflammation, highlighting new targets for mitigating brain edema.
-
L-Glutathione Reduced: Precision Redox Control in Cancer Res
2026-05-06
L-Glutathione Reduced from APExBIO empowers researchers to dissect cellular redox balance, streamline GST-affinity workflows, and probe metabolic vulnerabilities in cancer models. This guide translates the latest reference breakthroughs and proven protocols into actionable steps, troubleshooting tactics, and cross-validated data for reproducible, optimized assays.
-
Uremic Toxins Drive Protein Adsorption on PEO Surfaces in CK
2026-05-06
This study demonstrates that uremic toxins, such as 4-ethylphenyl sulfate, significantly increase plasma protein adsorption to poly(ethylene oxide) (PEO)-modified surfaces, even when PEO chain density is optimized. These findings highlight the necessity to account for disease-altered metabolite profiles when designing blood-contacting biomaterials for chronic kidney disease patients.
-
12-O-tetradecanoyl phorbol-13-acetate: Precision ERK/MAPK Ac
2026-05-05
12-O-tetradecanoyl phorbol-13-acetate (TPA) delivers rapid, tunable activation of PKC and ERK/MAPK pathways, unlocking advanced control in signal transduction research and skin cancer modeling. This article translates bench-proven workflows and troubleshooting strategies into actionable guidance, integrating the latest mechanistic insights and APExBIO’s validated TPA (SKU N2060) for reproducibility.